Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-12-18
2000-03-07
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514337, 514364, 514381, 514465, 548253, 548255, A61K 3136, C07D28504
Patent
active
06034105&
ABSTRACT:
A tachykinin antagonist is useful, alone or in conjunction with other agents, for altering circadian rhythmicity and alleviating circadian rhythm disorders and for enhancing and improving the quality of sleep.
REFERENCES:
patent: 5232929 (1993-08-01), Desai et al.
patent: 5242930 (1993-09-01), Baker et al.
patent: 5321032 (1994-06-01), Matsuo et al.
patent: 5538982 (1996-07-01), Hagan et al.
patent: 5612337 (1997-03-01), Baker et al.
patent: 5719147 (1998-02-01), Dorn et al.
patent: 5728695 (1998-03-01), Harrison et al.
patent: 5750549 (1998-05-01), Caldwell et al.
patent: 5877191 (1999-03-01), Caldwell et al.
Hagiwara, et al, Abstract of PCT Publication WO 91/12266, 1991.
Shibata, et al, Brain Research, 597, 257-263 (1992).
Shibata, et al, Neuroscience Letters, 168, 159-162 (1994).
Takatsuji, et al, Brain Research, 568,223-229 (1991).
Abe et al., Substance P receptor . . . , Brain Research vol. 708(1-2) pp. 135-42, 1996.
Shibata et al., Effect of substance P on Circadian rhythms . . . , Brain Research, vol. 597(2) pp. 257-63, 1993.
Mick et al., Marginal topography of neurons . . . , Molecular Brain Res., vol. 21(1-2) pp. 157-161, 1994.
Kim Vickie
MacMillan Keith D.
Merck & Co. , Inc.
Rose David L.
Thies J. Eric
LandOfFree
Alteration of circadian rhythmicity with a tachykinin antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alteration of circadian rhythmicity with a tachykinin antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alteration of circadian rhythmicity with a tachykinin antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363525